Latest News and Press Releases

PLYMOUTH, Minn., July 6, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that it has reached an agreement with the plaintiffs to settle the...

PLYMOUTH, Minn., June 21, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that the U.S. Food and Drug Administration (FDA) formally accepted for...

PLYMOUTH, Minn., May 18, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV), a global endovascular device company, today announced that it has filed the final module of its Premarket Approval (PMA)...

PLYMOUTH, Minn., May 17, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Shawn McCormick, senior vice president and chief financial officer, is scheduled to present at the 2010...

PLYMOUTH, Minn., May 10, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at Baird's 2010 Growth...

PLYMOUTH, Minn., May 4, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the Bank of America...

First Quarter Net Sales Increase 23% to $123.9 Million First Quarter GAAP EPS Increases to $0.09 Cash and Cash Equivalents Increase to $116.8 Million Full-Year 2010 Revenue and Earnings...

PLYMOUTH, Minn., April 26, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm...

PLYMOUTH, Minn., April 22, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) will release its 2010 first quarter financial results on Thursday, April 29, 2010, before regular market trading hours. The...

PLYMOUTH, Minn., April 8, 2010 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced the initiation of a supply agreement with MEDRAD Interventional™/Possis®. Under terms of the...